Generation of pancreatic endoderm from pluripotent stem cells using small molecules
AssigneesNovo Nordisk A/S, Takara Bio Europe AB
InventorsJenny Ekberg, Mattias Hansson, Ulrik Doehn, Katja Hess, Nina Funa
Life of this patent
Estimating the term…
Abstract
A method of producing pancreatic cells or pancreatic cell precursors expressing at least 5% PDX1/NKX6.1 double positive, comprising exposing definitive endoderm cells to an effective amount of one or more small molecules, to differentiate the human definitive endoderm cells into the pancreatic cells or pancreatic cell precursors. The present invention also relates to pancreatic endoderm cells produced by said methods and uses of said pancreatic endoderm cells.
Claims4
A cell culture medium comprising definitive endoderm cells, a BMP inhibitor, JNK inhibitor II, bFGF, and a retinoic acid receptor agonist.
Dependencies are inferred from the claim text.